MedTrace Logo

Registration Study for Rare Type of Pulmonary Hypertension

NCT03169010 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-10-02

No results posted yet for this study

Summary

The knowledge on the rare type of pulmonary hypertension which can not be explained by left heart disease, respiratory disease or congenital heart disease is very limited. Investigators aim to setup a national registration study for the rare type of pulmonary hypertension, to understand the natural history, survival, progression, genetic and environmental contributions to disease.

Conditions

  • Pulmonary Hypertension

Interventions

OTHER

laboratory biomarker analysis

Laboratory results will be analysed to identify disease related biomarkers.

GENETIC

Genetic analysis

Gene sequencing results will be analysed to identify disease related mutations.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Zhi-Cheng JING, MD. PhD. · Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-06
Primary Completion
2040-12-31
Completion
2040-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03169010 on ClinicalTrials.gov